NRIX Competitors & Alternatives
Compare Nurix Therapeutics Inc with similar stocks in the same industry
Biotechnology
NRIX
Main Stock$26.02
Tradestie Score
47
Market Cap
$718.62M
P/E Ratio
10.3
Revenue Growth
84.3%
Analyst Upside
+32.6%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 48 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$21.10
|
$3.09B | - | 70 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$26.38
|
$3.08B | - | 59 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$40.50
|
$3.03B | - | 48 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$35.95
|
$3.02B | - | 60 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$62.24
|
$3.01B | - | 73 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 50 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$15.92
|
$2.89B | - | 39 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$28.38
|
$2.85B | - | 54 | Compare |
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.49
|
$2.56B | 18.2 | 51 | Compare |
More NRIX Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry